Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Peer Review reports

Original Submission
13 May 2014	Submitted	Original manuscript
14 May 2014	Author responded	Author comments - Luis Cirera
Resubmission - Version 2
14 May 2014	Submitted	Manuscript version 2
7 Sep 2014	Reviewed	Reviewer Report - Jaw-Yuan Wang
9 Sep 2014	Reviewed	Reviewer Report - Kohei Shitara
6 Oct 2014	Author responded	Author comments - Luis Cirera
Resubmission - Version 3
6 Oct 2014	Submitted	Manuscript version 3
10 Oct 2014	Reviewed	Reviewer Report - Jaw-Yuan Wang
19 Oct 2014	Reviewed	Reviewer Report - Kohei Shitara
3 Nov 2014	Author responded	Author comments - Luis Cirera
Resubmission - Version 4
3 Nov 2014	Submitted	Manuscript version 4
Publishing
11 Nov 2014	Editorially accepted
22 Nov 2014	Article published	10.1186/1471-2407-14-865

Back to article page